In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond
- PMID: 28017837
- DOI: 10.1016/j.drudis.2016.12.008
In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond
Abstract
In situ gelling delivery systems for the ocular administration of drugs has been a major focus of research over the past two decades, improving the treatment of diseases of the anterior segment of the eye by simple, safe, and reproducible drug administration. This drug delivery strategy results in high ocular bioavailability by avoiding rapid precorneal clearance resulting from nasolacrimal drainage and eye blinking. However, the development of such unconventional forms requires many parameters to be mastered, such as gelation time, viscoelastic behavior, mucoadhesion, and sustained release. In this review, we describe and assess the in vitro and in vivo methods available for in situ gelling ophthalmic delivery systems, highlighting the advantages of existing methods and, in some cases, the need for more relevant assays.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.Int J Pharm. 2020 Mar 30;578:119184. doi: 10.1016/j.ijpharm.2020.119184. Epub 2020 Feb 26. Int J Pharm. 2020. PMID: 32112932
-
Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.Drug Dev Ind Pharm. 2016 Sep;42(9):1406-23. doi: 10.3109/03639045.2015.1137306. Epub 2016 Jan 29. Drug Dev Ind Pharm. 2016. PMID: 26716613
-
Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.Int J Pharm. 2020 Jan 25;574:118734. doi: 10.1016/j.ijpharm.2019.118734. Epub 2019 Nov 6. Int J Pharm. 2020. PMID: 31705970
-
Controlled and continuous release ocular drug delivery systems: pros and cons.Curr Drug Deliv. 2012 Jul;9(4):421-30. doi: 10.2174/156720112801323125. Curr Drug Deliv. 2012. PMID: 22640036 Review.
-
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications.Drug Discov Today. 2019 Aug;24(8):1575-1586. doi: 10.1016/j.drudis.2019.05.036. Epub 2019 Jun 5. Drug Discov Today. 2019. PMID: 31175956 Review.
Cited by
-
Design, Characterization and Pharmacokinetic-Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma.Pharmaceutics. 2023 Jan 25;15(2):405. doi: 10.3390/pharmaceutics15020405. Pharmaceutics. 2023. PMID: 36839727 Free PMC article.
-
Structural Characterization and Optimization of a Miconazole Oral Gel.Polymers (Basel). 2022 Nov 18;14(22):5011. doi: 10.3390/polym14225011. Polymers (Basel). 2022. PMID: 36433136 Free PMC article.
-
Advances in Nanogels for Topical Drug Delivery in Ocular Diseases.Gels. 2023 Apr 2;9(4):292. doi: 10.3390/gels9040292. Gels. 2023. PMID: 37102904 Free PMC article. Review.
-
Biodegradable silicon nanoneedles for ocular drug delivery.Sci Adv. 2022 Apr;8(13):eabn1772. doi: 10.1126/sciadv.abn1772. Epub 2022 Mar 30. Sci Adv. 2022. PMID: 35353558 Free PMC article.
-
Review of Contemporary Self-Assembled Systems for the Controlled Delivery of Therapeutics in Medicine.Nanomaterials (Basel). 2021 Jan 21;11(2):278. doi: 10.3390/nano11020278. Nanomaterials (Basel). 2021. PMID: 33494400 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous